×

IMMUNOTHERAPY AGAINST SEVERAL TUMORS, SUCH AS LUNG CANCER, INCLUDING NSCLC

  • US 20190322703A1
  • Filed: 06/18/2019
  • Published: 10/24/2019
  • Est. Priority Date: 08/05/2013
  • Status: Active Grant
First Claim
Patent Images

1. A method of eliciting an immune response in a patient who has glioblastoma, comprising administering to the patient a composition comprising a population of activated T cells that kill the cancer cells that present a peptide consisting of the amino acid sequence SLYKGLLSV (SEQ ID NO:

  • 56),wherein the activated T cells are produced by contacting T cells with an antigen presenting cell that presents the peptide in a complex with a human class I or II MHC molecule on the surface of the antigen presenting cell.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×